{"id":"NCT01023815","sponsor":"Novartis","briefTitle":"Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.","officialTitle":"Once-a-day Regimen or Steroid Withdrawal in de Novo Kidney Transplant Recipients Treated With Everolimus, Cyclosporine and Steroids: a 12-month, Prospective, Randomized, Multicenter, Open-label Study. The EVIDENCE Study (EVerolImus Once-a-Day rEgimen With Neoral Versus Corticosteroid Elimination).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2009-12-02","resultsPosted":"2013-11-14","lastUpdate":"2016-07-19"},"enrollment":330,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["de Novo Kidney Transplant Recipients","Renal Transplantation"],"interventions":[{"type":"DRUG","name":"everolimus","otherNames":["Certican®)"]},{"type":"DRUG","name":"cyclosporine","otherNames":["CsA, Sandimmun® Neoral®"]},{"type":"DRUG","name":"Prednison (continuous steroids)","otherNames":[]}],"arms":[{"label":"Group A -Once-a-day regimen","type":"EXPERIMENTAL"},{"label":"Group B - Steroid Withdrawal group","type":"EXPERIMENTAL"},{"label":"Group C - Standard twice-a-day group","type":"ACTIVE_COMPARATOR"},{"label":"Not Randomized Population (NRP)","type":"EXPERIMENTAL"}],"summary":"This study will compare the following immunosuppressive regimens in recipients of kidney transplantation: A) everolimus, cyclosporine and steroids given once-a-day; B) everolimus and cyclosporine given twice a day with steroid withdrawal; C) everolimus, cyclosporine given twice a day and continuous steroids. The purpose of this study is to evaluate regimens A and B in comparison with the control group (group C) for efficacy, using as main endpoint the treatment failure rate, a composite endpoint including death, graft loss, BPAR and lost to follow-up between randomization and Month 12.","primaryOutcome":{"measure":"Treatment Failure Rate","timeFrame":"Between randomization (Month 3) and Month 12","effectByArm":[{"arm":"Group A - Once-a-day Regimen","deltaMin":3,"sd":null},{"arm":"Group B - Steroid Withdrawal Group","deltaMin":10,"sd":null},{"arm":"Group C - Standard Twice-a-day Group","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":null},"locations":{"siteCount":28,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":65,"n":144},"commonTop":["Anaemia","Hyperlipidaemia","Urinary tract infection","Hypertension","Complications of transplanted kidney"]}}